96 related articles for article (PubMed ID: 15780555)
1. Axillary recurrence in breast cancer.
Kingsmore DB; Hole DJ; Gillis CR; George WD
Eur J Surg Oncol; 2005 Apr; 31(3):226-31. PubMed ID: 15780555
[TBL] [Abstract][Full Text] [Related]
2. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
Schouten van der Velden AP; Van Dijck JA; Wobbes T
Eur J Surg Oncol; 2007 May; 33(4):424-9. PubMed ID: 17084060
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
4. Consequences of axillary recurrence after conservative breast surgery.
Fredriksson I; Liljegren G; Arnesson LG; Emdin SO; Palm-Sjövall M; Fornander T; Holmqvist M; Holmberg L; Frisell J
Br J Surg; 2002 Jul; 89(7):902-8. PubMed ID: 12081741
[TBL] [Abstract][Full Text] [Related]
5. Inadequate treatment of symptomatic breast cancer.
Kingsmore DB; Hole DJ; Gillis CR; George WD
Br J Surg; 2005 Apr; 92(4):422-8. PubMed ID: 15609383
[TBL] [Abstract][Full Text] [Related]
6. Quantitative molecular diagnosis of axillary drainage fluid for prediction of locoregional failure in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.
Zhang Y; Ma QY; Dang CX; Moureau-Zabotto M; Chen WK
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):505-11. PubMed ID: 16257133
[TBL] [Abstract][Full Text] [Related]
7. Axillary staging in women with small invasive breast tumours.
della Rovere GQ; Bonomi R; Ashley S; Benson JR
Eur J Surg Oncol; 2006 Sep; 32(7):733-7. PubMed ID: 16814511
[TBL] [Abstract][Full Text] [Related]
8. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
9. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
10. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
Strom EA; Woodward WA; Katz A; Buchholz TA; Perkins GH; Jhingran A; Theriault R; Singletary E; Sahin A; McNeese MD
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1508-13. PubMed ID: 16169678
[TBL] [Abstract][Full Text] [Related]
11. Management and outcomes of isolated axillary node recurrence in breast cancer.
Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
[TBL] [Abstract][Full Text] [Related]
12. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
[TBL] [Abstract][Full Text] [Related]
13. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
14. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
[TBL] [Abstract][Full Text] [Related]
16. Selective axillary node sampling and radiotherapy to the axilla in the management of breast cancer.
Tanguay JS; Ford DR; Sadler G; Buckley L; Uppal H; Cross J; Holmes N; Fortes Mayer K; Fernando I
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):677-82. PubMed ID: 18722758
[TBL] [Abstract][Full Text] [Related]
17. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.
Dinshaw KA; Sarin R; Budrukkar AN; Shrivastava SK; Deshpande DD; Chinoy RF; Badwe R; Hawaldar R
J Surg Oncol; 2006 Aug; 94(2):105-13. PubMed ID: 16847919
[TBL] [Abstract][Full Text] [Related]
18. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
Hwang RF; Gonzalez-Angulo AM; Yi M; Buchholz TA; Meric-Bernstam F; Kuerer HM; Babiera GV; Tereffe W; Liu DD; Hunt KK
Cancer; 2007 Aug; 110(4):723-30. PubMed ID: 17587208
[TBL] [Abstract][Full Text] [Related]
19. False-negative sentinel lymph node biopsy.
van Wely BJ; Smidt ML; de Kievit IM; Wauters CA; Strobbe LJ
Br J Surg; 2008 Nov; 95(11):1352-5. PubMed ID: 18844270
[TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival.
Grabau D; Jensen MB; Rank F; Blichert-Toft M
APMIS; 2007 Jul; 115(7):828-37. PubMed ID: 17614850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
